Robert D. Mccroskey

Oncology
1624 S I St Ste 305
Tacoma, WA 98405

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial.

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial.

Journal: The Lancet. Haematology
Published: February 22, 2019
Showing 1-1 of 1

Last Updated: 09/26/2026